FDA inspection
KinOmega Biopharm Inc.: FDA inspection ending Jan 24, 2025
FDA inspection 1260826 · Voluntary Action Indicated (VAI) · Deyang
Key facts
| Inspection ID | 1260826 |
|---|---|
| Firm | KinOmega Biopharm Inc. |
| FEI number | 3009754809 |
| Address | No. 161 South Yinghuashan Road |
| City | Deyang |
| Country | China |
| Fiscal year | 2025 |
| Inspection end date | Jan 24, 2025 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data